Neurogene Inc (NGNE) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Neurogene Inc (US:NGNE), trading at 33.60. In 2024, Neurogene Inc generated $925,000 in revenue and -$71.41 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Neurogene Inc is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 33.60
- Recent Revenue (2024): $925,000
- Free Cash Flow (2024): -$71.41 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.